Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSPIRA TECHNOLOGIES OXY B.H.N. LTD.

(IINN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inspira Technologies Rise Climb After Co. Contracts GlobalLogic

09/22/2021 | 10:54am EDT

By Robb M. Stewart

Inspira Technologies Oxy B.H.M. Ltd.'s shares advanced Wednesday after the medical-device company contracted a unit of Hitachi Ltd. for the acquisition of an algorithm-enhanced digital platform for its early extracorporeal respiratory support system.

In morning trading, the shares were 14% higher at $3.33.

Inspira said it is progressing toward the production phase of its ART device's "brain," an algorithm-enhanced platform. ART is designed to provide oxygenation of blood and removal of carbon dioxide from the blood.

The company said that with Hitachi's GlobalLogic, it can integrate an advanced digital algorithm into the control platform and provide a more advanced digital experience.

The company said the product includes a feature designed to manage the early rebalancing of patient oxygen saturation levels. It also includes a digital algorithm-enhanced platform designed to activate and control proprietary technologies and data collected from advanced sensors that measure oxygen saturation, blood temperature, haemoglobin, and haematocrit as well as pressure and flow of blood, it said.

The ART device hasn't yet been tested or used in humans and hasn't been approved by the U.S. Food and Drug Administration.

In mid-July, Tokyo-based Hitachi completed the acquisition of GlobalLogic, a digital-product engineering company.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

09-22-21 1053ET

Stocks mentioned in the article
ChangeLast1st jan.
HITACHI, LTD. -0.10% 6685 End-of-day quote.64.45%
INSPIRA TECHNOLOGIES OXY B.H.N. LTD. -8.47% 2.27 Delayed Quote.0.00%
All news about INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
10/13INSPIRA TECHNOLOGIES TO PRESENT IN-P : Philips Ventures, Microsoft, Google
PR
09/30INSPIRA TECHNOLOGIES : to Host COVID-19 Virtual Conference on October 6
PR
09/22Inspira Technologies Rise Climb After Co. Contracts GlobalLogic
DJ
09/22INSPIRA TECHNOLOGIES OXY B H N : The Company Contracted GlobalLogic, a Hitachi Group Compa..
PU
09/22Inspira Technologies Oxy B.H.N. Ltd. Contracted Globallogic, A Hitachi Group Company, f..
CI
09/15INSPIRA TECHNOLOGIES OXY B H N : Files Patent Application in Israel for Supportive Device ..
MT
09/15Inspira Technologies Oxy B.H.N. Ltd. Files a Patent Application for a Supportive Device..
CI
09/09INSPIRA TECHNOLOGIES : to Participate in Upcoming Conferences in September
PR
08/26INSPIRA TECHNOLOGIES OXY B H N : Aegis Capital Starts Inspira Technologies Oxy BHN at Buy ..
MT
08/18INSPIRA TECHNOLOGIES OXY B H N : Reached Important Milestone as It Completed a Pump Bench ..
PU
More news
Analyst Recommendations on INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -11,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,49x
Yield 2021 -
Capitalization 17,7 M 17,7 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees -
Free-Float 66,2%
Chart INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
Duration : Period :
Inspira Technologies Oxy B.H.N. Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 2,27 $
Average target price 9,00 $
Spread / Average Target 296%
EPS Revisions
Managers and Directors
Dagi Shahar Ben-Noon Chief Executive Officer & Director
Joe Hayon President, Chief Financial Officer & Director
Benad Goldwasser Chairman
Udi Nussinovitch Chief Scientific Officer & Director
Avi Shabtai COO, Vice President-Research & Development
Sector and Competitors